Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,080 | 5 | 46.8% |
| Current or prospective ownership or investment interest | $7,431 | 2 | 26.6% |
| Food and Beverage | $4,458 | 434 | 15.9% |
| Travel and Lodging | $1,903 | 3 | 6.8% |
| Education | $1,103 | 10 | 3.9% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $11,635 | 84 | $0 (2023) |
| Innovative Medical Technologies, LLC | $7,431 | 7 | $0 (2021) |
| Endo Pharmaceuticals Inc. | $4,595 | 42 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $1,413 | 212 | $0 (2024) |
| Coloplast Corp | $1,367 | 6 | $0 (2020) |
| UROVANT SCIENCES INC | $253.61 | 32 | $0 (2022) |
| PFIZER INC. | $195.35 | 16 | $0 (2024) |
| ABBVIE INC. | $181.30 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $120.90 | 9 | $0 (2023) |
| Boston Scientific Corporation | $106.07 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $682.28 | 100 | Sumitomo Pharma America, Inc. ($610.64) |
| 2023 | $1,099 | 131 | Sumitomo Pharma America, Inc. ($802.52) |
| 2022 | $412.92 | 41 | UROVANT SCIENCES INC ($253.61) |
| 2021 | $125.77 | 9 | Astellas Pharma US Inc ($125.77) |
| 2020 | $127.17 | 8 | Coloplast Corp ($40.29) |
| 2019 | $873.69 | 57 | Astellas Pharma US Inc ($450.29) |
| 2018 | $4,195 | 60 | Astellas Pharma US Inc ($3,124) |
| 2017 | $20,459 | 53 | Astellas Pharma US Inc ($7,860) |
All Payment Transactions
459 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: UROLOGY | ||||||
| 12/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $2.37 | General |
| Category: UROLOGY | ||||||
| 12/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: UROLOGY | ||||||
| 12/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: UROLOGY | ||||||
| 12/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.62 | General |
| Category: UROLOGY | ||||||
| 12/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.59 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: UROLOGY | ||||||
| 11/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: UROLOGY | ||||||
| 11/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: UROLOGY | ||||||
| 11/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: UROLOGY | ||||||
| 11/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: UROLOGY | ||||||
| 11/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.86 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: UROLOGY | ||||||
| 10/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: UROLOGY | ||||||
| 10/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: UROLOGY | ||||||
| 10/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: UROLOGY | ||||||
| 10/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.76 | General |
| Category: UROLOGY | ||||||
| 10/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.79 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,143 | 5,263 | $1.1M | $138,143 |
| 2022 | 18 | 1,078 | 5,970 | $847,318 | $121,573 |
| 2021 | 23 | 1,391 | 6,994 | $542,497 | $148,004 |
| 2020 | 30 | 1,788 | 7,921 | $503,265 | $151,110 |
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 238 | 287 | $55,076 | $23,671 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 315 | 377 | $49,275 | $21,611 | 43.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 18 | 165 | $688,006 | $21,080 | 3.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 20 | 3,700 | $54,612 | $18,404 | 33.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 74 | 87 | $55,680 | $14,569 | 26.2% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 25 | 28 | $94,108 | $11,837 | 12.6% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 20 | 36 | $36,936 | $9,512 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $16,951 | $6,009 | 35.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 20 | 20 | $9,160 | $2,051 | 22.4% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 11 | 11 | $6,545 | $1,805 | 27.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $4,106 | $1,580 | 38.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 15 | 15 | $26,667 | $1,555 | 5.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,846 | $1,262 | 32.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 26 | $2,300 | $962.56 | 41.9% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 18 | 31 | $3,348 | $779.96 | 23.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 169 | 261 | $5,481 | $572.74 | 10.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 54 | 62 | $6,882 | $419.60 | 6.1% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 17 | 19 | $1,786 | $357.20 | 20.0% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 15 | 48 | $260.64 | $105.66 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 366 | 433 | $58,455 | $25,640 | 43.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 28 | 4,550 | $58,195 | $22,272 | 38.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 15 | 113 | $481,041 | $15,517 | 3.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 138 | 156 | $30,576 | $13,572 | 44.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 60 | 72 | $46,080 | $12,582 | 27.3% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2022 | 28 | 42 | $43,092 | $11,747 | 27.3% |
About Dr. David Pollifrone, MD
Dr. David Pollifrone, MD is a Urology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215901574.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Pollifrone, MD has received a total of $27,974 in payments from pharmaceutical and medical device companies, with $682.28 received in 2024. These payments were reported across 459 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,080).
As a Medicare-enrolled provider, Pollifrone has provided services to 5,400 Medicare beneficiaries, totaling 26,148 services with total Medicare billing of $558,831. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Fort Wayne, IN
- Active Since 02/14/2006
- Last Updated 04/03/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1215901574
Products in Payments
- Myrbetriq (Drug) $7,795
- XIAFLEX (Biological) $4,411
- MYRBETRIQ (Drug) $2,922
- GEMTESA (Drug) $1,667
- MALE INCONTINENCE (Device) $715.91
- TITAN (Device) $609.29
- XTANDI (Drug) $469.10
- AVEED (Biological) $184.73
- BOTOX (Biological) $118.42
- ZYTIGA (Drug) $98.72
- Erleada (Drug) $86.39
- Axumin (Drug) $72.75
- LUPRON DEPOT (Drug) $72.12
- TOVIAZ (Drug) $69.06
- UroLift (Device) $47.50
- FIRMAGON (Drug) $45.73
- Xofigo (Drug) $42.87
- BMD-Bard Skylite (Device) $42.52
- Bulkamid (Device) $36.02
- BOTOX THERAPEUTIC (Biological) $35.69
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Fort Wayne
George Martin, M.d, M.D
Urology — Payments: $20,605
Mark Dabagia, Md, MD
Urology — Payments: $16,775
Dr. David Turk, Md, MD
Urology — Payments: $10,321
Adam Thomas, Md, MD
Urology — Payments: $9,310
Claire Aubrey, D.o, D.O
Urology — Payments: $6,018
Dr. Eric Hick, D.o, D.O
Urology — Payments: $5,800